Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2016
DOI: 10.5958/2394-2754.2016.00043.6
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the clinical efficacy and safety of progestogens in the management of threatened and recurrent miscarriage in early pregnancy-A review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
1
0
Order By: Relevance
“…Dydrogesterone is highly selective for progesterone receptors and lack estrogenic, androgenic, anabolic and corticoid properties which makes it different from other progestogens. It doesn't suppress the pituitary-gonadal axis making it a suitable management option for women with threatened miscarriage or any other pregnancy related disorders [7].…”
Section: Discussionmentioning
confidence: 99%
“…Dydrogesterone is highly selective for progesterone receptors and lack estrogenic, androgenic, anabolic and corticoid properties which makes it different from other progestogens. It doesn't suppress the pituitary-gonadal axis making it a suitable management option for women with threatened miscarriage or any other pregnancy related disorders [7].…”
Section: Discussionmentioning
confidence: 99%
“…A fetus or embryo that is expelled from the uterus before 20 weeks of gestation or with a birth weight of less than 500 g is said to have experienced a miscarriage. A reasonably frequent pregnancy problem that affects 20% of all pregnancies is threatened miscarriage (1) .…”
Section: Introductionmentioning
confidence: 99%